The 2020 Multidisciplinary Head and Neck Cancers Symposium takes place February 27-29 in Scottsdale, Arizona. This two-and-a-half-day meeting for the entire head and neck cancer community provides the most up-to-date information on multidisciplinary therapies, clinical research, treatment strategies, supportive care, scientific breakthroughs and toxicity mitigation.
The meeting is cosponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the American Head and Neck Society (AHNS) and the Society for Immunotherapy of Cancer (SITC).
For more information, visit the symposium website and schedule of events.
Complimentary registration is available for professional journalists representing media organizations for the express purpose of gathering news and information to produce press coverage of the symposium. Press registration is open to representatives of print, broadcast and online media outlets, including health care trade media (collectively known as press), as well as public information officers from educational institutions, government agencies and nonprofit cancer research organizations presenting research at the symposium.
For more information on press registration or to register as press for the meeting, contact ASTRO's media relations team.
Applicants may be asked to provide media credentials, a letter of assignment and/or bylined articles. Exhibitors are not permitted to register as press unless they can provide proof of editorial assignment from an accredited news organization that meets the above criteria. Public relations, marketing and/or advertising representatives, financial analysts, book publishers and book authors, and individuals from communications, print or online promotion services are welcome to register as regular attendees, however, they are not permitted to register as press. ASTRO reserves the right to bar from this and future meetings any journalist who misuses press privileges to engage in activities other than journalistic pursuits.
Press Office and Contacts
Rooms are available to reserve for media interviews at the symposium on a first-come, first-served basis.
All media-related questions about the press program, press office, press registration and expert availability may be directed to ASTRO’s media relations team.
Embargo Policy and Access to Abstracts
All abstracts to be presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium are embargoed until 7:00 a.m. Mountain time, Thursday, February 27, 2020, or until they are presented at an ASTRO news briefing, whichever occurs first. The embargo policy applies to all abstracts regardless of whether information is obtained from another source.
Embargo violations by media professionals may result in suspension of credentials at the symposium as well as future meetings and may also impact the ability to receive advance media materials for future meetings. Embargo violations by abstract authors and/or sponsors may result in removal of the abstract from the scientific program. Abstract authors are responsible for notifying financial and other sponsors about this embargo policy.
Questions about the embargo policy may be directed to ASTRO’s media relations team.
The full text of the abstracts selected for oral and poster presentation will be available online at the start of the meeting. Abstracts also will be published in the April 2020 issue of the International Journal of Radiation Oncology • Biology • Physics (www.redjournal.org).
News Planning Team
Volunteers from the symposium leadership select abstracts for inclusion on the press program. Members of the 2020 Multidisciplinary Head and Neck Cancers Symposium News Planning Team include:
- Brian O'Sullivan, MD, FASTRO, Princess Margaret Hospital
- Charu Aggarwal, MD, MPH, University of Pennsylvania
- Francis P. Worden, MD, University of Michigan Health System
- Maie St. John, MD, PhD, UCLA Medical Center
- Robert L. Ferris, MD, PhD, University of Pittsburgh Medical Center
- Sue Yom, MD, PhD, University of California, San Francisco
For COI disclosures, contact ASTRO's media relations team.